Advisors Preferred’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Advisors Preferred's XBI Position: Q1 2026 in Review
Advisors Preferred sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 161 shares — an estimated $19.6K sold.
Advisors Preferred first reported a position in XBI in Q4 2013 and held it in 6 quarters. The position peaked at $2.26M in Q1 2015. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Advisors Preferred reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
- Advisors Preferred sold 161 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $19.6K.
- Advisors Preferred first reported a position in State Street SPDR S&P Biotech ETF in Q4 2013 and held it in 6 quarters.
- Advisors Preferred's State Street SPDR S&P Biotech ETF position peaked at $2.26M in Q1 2015.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Advisors Preferred's 13F filing for Q1 2026, filed 5 May 2026.